These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14698035)

  • 41. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).
    Tedesco D; Lukas J; Reed SI
    Genes Dev; 2002 Nov; 16(22):2946-57. PubMed ID: 12435635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis.
    Naujokat C; Daniel V; Bauer TM; Sadeghi M; Opelz G
    Biochem Biophys Res Commun; 2003 Oct; 310(2):347-54. PubMed ID: 14521916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
    Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.
    Zhu M; Harshbarger WD; Robles O; Krysiak J; Hull KG; Cho SW; Richardson RD; Yang Y; Garcia A; Spiegelman L; Ramirez B; Wilson CT; Yau JA; Moore JT; Walker CB; Sacchettini JC; Liu WR; Sieber SA; Smith JW; Romo D
    Bioorg Med Chem; 2017 Jun; 25(11):2901-2916. PubMed ID: 28236510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new structural class of proteasome inhibitors that prevent NF-kappa B activation.
    Lum RT; Kerwar SS; Meyer SM; Nelson MG; Schow SR; Shiffman D; Wick MM; Joly A
    Biochem Pharmacol; 1998 May; 55(9):1391-7. PubMed ID: 10076530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism.
    Demasi M; Davies KJ
    FEBS Lett; 2003 May; 542(1-3):89-94. PubMed ID: 12729904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with increased expression of sterol regulatory element-binding protein 2 and LDL receptor.
    Kuhn DJ; Burns AC; Kazi A; Dou QP
    Biochim Biophys Acta; 2004 Jun; 1682(1-3):1-10. PubMed ID: 15158750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
    Lu Y; Zi X; Pollak M
    Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
    McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
    Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
    Wu Y; Luo H; Kanaan N; Wu J
    J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin.
    Park BS; Baek SJ; Song KH; Kim KH; Jeong SJ; Jeong MH; Seo SY; Lee SW; Yoo KS; Yoo YH
    Nutr Cancer; 2002; 42(2):248-55. PubMed ID: 12416267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
    García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
    Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
    Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
    Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heat-processed neoginseng, KG-135, down-regulates G1 Cyclin-dependent kinase through the proteasome-mediated pathway in HeLa cells.
    Lee WH; Choi JS; Kim HY; Park JH; Lee SK; Surh YJ
    Oncol Rep; 2009 Feb; 21(2):467-74. PubMed ID: 19148524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteasome inhibitors.
    Reboud-Ravaux M
    Prog Mol Subcell Biol; 2002; 29():110-25. PubMed ID: 11908069
    [No Abstract]   [Full Text] [Related]  

  • 57. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
    Murray EJ; Bentley GV; Grisanti MS; Murray SS
    Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the combination of a proteasome inhibitor (PSI) and an inhibitor of ubiquitin-ligases (Leu-Ala) on the ultrastructure of human leukemic U937 cells.
    Biały LP; Ziemba H; Pleban E; Wójcik C
    Folia Histochem Cytobiol; 2002; 40(2):135-6. PubMed ID: 12056612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential regulation of components of the ubiquitin-proteasome pathway during lens cell differentiation.
    Guo W; Shang F; Liu Q; Urim L; West-Mays J; Taylor A
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1194-201. PubMed ID: 15037588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis.
    Nam S; Smith DM; Dou QP
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1083-8. PubMed ID: 11588135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.